Dr Mina Farahani
Offers Perspective on
MIEBO^® for DED

Dr Mina Farahani

Cornea and Cataract Specialist

Learn more

Dr Mina Farahani is a paid consultant of Bausch & Lomb, Inc.

For the signs and symptoms of dry eye disease

IMPORTANT SAFETY INFORMATION

MIEBO should not be administered while wearing contact lenses. Contact lenses should be removed before use and for at least 30 minutes after administration of MIEBO
Instruct patients to instill one drop of MIEBO into each eye four times daily
The safety and efficacy in pediatric patients below the age of 18 have not been established
The most common ocular adverse reaction was blurred vision (1% to 3% of patients reported blurred vision and conjunctival redness)

MIEBO^® (perfluorohexyloctane ophthalmic solution) is used to treat the signs and symptoms of dry eye disease.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/
medwatch or call 1-800-FDA-1088.

Click here for full prescribing Information for MIEBO.